Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

QAI/ML-SaMD: A Hybrid Health-Technology Quantifiable Quality Metric for Artificial Intelligence/Machine Learning-Based Software as a Medical Device.

PMID: 42651356 ·

Shouki A Ebad

JournalHealthcare (Basel, Switzerland)
Year
PMID42651356

Abstract

Background: The increasing integration of Artificial Intelligence (AI) and Machine Learning (ML) into medical devices necessitates robust quality evaluation methods. However, existing approaches remain qualitative, sector-specific, or focused on isolated attributes, leaving a gap in quantifiable assessment for AI/ML-driven Software as a Medical Device (SaMD). Objective: This study introduces QAI/ML-SaMD, a novel hybrid metric that provides a comprehensive, quantifiable measure of AI/ML-SaMD qual

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.